Key facts
- ISS recommended voting for all Pacira director nominees.
- ISS stated there is a compelling reason to support all management nominees.
- ISS noted the dissident has not presented a compelling case for change.
Pacira BioSciences is facing a proxy battle where a dissident shareholder is attempting to gain board seats. The recommendation from ISS, a key influential proxy advisory firm, is a significant development in this contest, as their advice often guides institutional investors' voting decisions.